Inferior Vena Cava (IVC) Filter Market - Trends, Size & Outlook (2024-2032)

Inferior Vena Cava (IVC) Filter Market Size Was Valued at USD 813.04 Million in 2023, and is Projected to Reach USD 1,770.22 Million by 2032, Growing at a CAGR of 9.03% From 2024-2032. IVC Filter Market The Inferior Vena Cava (IVC) Filter Market are medical devices implanted in the inferior vena cava, that is, the largest vein which carries deoxygenated blood from the lower part of the body to the heart with a view to stopping blood clots traveling to the lungs and thereby developing pulmonary embolism. IVC filters are generally applied to patients suffering at risk for venous thromboembolism who cannot take anticoagulant therapy. IVC filter market is seen to be growing steadily since the instances of venous thromboembolism and pulmonary embolism are increasing rapidly, and these conditions may become fatal if it is not properly managed. IVC filters have provided a significant advantage in patients who are contraindicated for anticoagulant therapy or have a high risk of developing pulmonary embolism. These devices can be permanent or retrievable, according to the clinical situation and patient needs, and are minimally invasive. The demand for these devices has increased because more medical professionals now prescribe IVC filters to prevent primary thrombosis. High-risk patients who undergo surgery or trauma recovery are targeted prescribers of these filters. Technological advancement in IVC filters has thus added to the growth in demand. Especially, retrievable filters, which are removed after the risk of PE subsides, have become popular because they offer flexibility in treatment. However, long-term efficacy and complications such as migration, breakage, or inability to retrieve have been of some concern and thus an impetus for research and innovation to improve upon them. Despite these challenges, demand for IVC filters continues to soar in developed and emerging markets. Improving consciousness about VTE and healthcare infrastructure have boosted the situation; however, judicial scrutiny and the different guidelines followed in different regions deter the growth of the market. However, with investments by manufacturers into better designs of the filters along with enhancements in safety concerns, the IVC filter market is going to boom in the years ahead. Inferior Vena Cava (IVC) Filter Market Trend Analysis: Increasing Use of Retrievable Filters Another critical trend for IVC filters is from permanent ones to retrievable filters. Retrievable filters have the added advantage of being removed after the risk for PE has abated. This decreases the likelihood of future complications that may occur secondary to the filter's presence, such as filter migration, fracture, or perforation, which can develop over time. As a result, retrievable filters are becoming at the forefront of healthcare providers for use in applications where they would be needed only temporarily to prevent PE. Enhancements in design and safety lay the ground for this trend towards retrievable filters, which indeed allows for a more successful and less invasive retrieval. The demand for retrievable filters is going to go upward with the shift of medical guidelines toward certain instances wherein they should have an application instead of permanent ones. Rising Demand in Emerging Markets The major opportunity for growth in the IVC filter market is mainly due to increasing demand in the emerging markets, especially from the Asia-Pacific and Latin America regions. Improving health infrastructure and increasing awareness of VTE and PE drive the demand for effective preventive measures with IVC filters. The continuously growing middle-class population in these regions along with increased access to healthcare services, drive up the adoption of advanced medical devices, such as IVC filters. The government initiatives in these regions focus on the expansion of healthcare and medical technology. Hence, such manufacturers of IVC filters have enormous opportunities to exploit this market by offering low-cost, innovative products customized according to the need in the region. Thus, the market is expected to grow at a tremendous rate as companies identify opportunities to venture into these regions through strategic partnerships and product innovations. Inferior Vena Cava (IVC) Filter Market Segment Analysis: Inferior Vena Cava (IVC) Filter Market is Segmented on the basis of Product Type, Material, Application, End User, and Region By Product Type, Permanent IVC Filters segment is expected to dominate the market during the forecast period Permanent IVC Filters: Permanent IVC filters are left in the body lifelong and provide long-term protection against pulmonary embolism (PE). The majority of their indications are for patients who remain at high risk for VTE, including those for whom anticoagulation is contraindicated. But such devices left permanently in the inferior vena cava hold risks of device migration or other late complications, driving a trend toward retirable systems in most cases. Retrievable IVC Filters: Retrievable IVC filters are increasingly preferred due to their removal capability once the risk of PE subsides, and so flexibility in treating the patient. These filters have remained the first choice for patients with temporary conditions, such as post-surgery care or trauma recovery, where the risk of VTE is of short duration. As retrieval success rates increase and filter designs improve, retrievable IVC filters are likely to become a significant market segment. By Application, Preventive Care of Pulmonary Embolism (PE) segment expected to held the largest share IVC filters are used for the management of VTE, especially in patients who don't respond to anticoagulants or even have contraindications to its use. In those patients who have had DVTs before and are at risk of developing PEs, IVC filters represent some added protection. The use of filters in the treatment of VTE continues to grow, especially with the increase in global statistics related to VTE incidence, both due to population aging and the ever-growing number of surgical procedures. Preventive Care of Pulmonary Embolism (PE): IVC filters are used in preventive care as an antidote that serves to prevent PE by avoiding blockage in high risk patients, such as in those who undergo major surgeries or recover from trauma. These filters prevent the clots from reaching the lungs and are, therefore, perceived as fundamental in the treatment management of patients with potential risk factors. Increased awareness of the risks of PE, along with the realized imperative for proactive treatment, has also seen the use of IVC filters in preventive care increase recently. Inferior Vena Cava (IVC) Filter Market Regional Insights: North America is Expected to Dominate the Market Over the Forecast period North America has the highest market share in the IVC filter market due to the advanced healthcare infrastructure, a higher incidence of VTE, and widespread awareness concerning pulmonary embolism risks. The region has a significant demand for permanent as well as retrievable IVC filters; this is primarily attributed to an age group having increased elderly population, increasing number of surgeries, and trauma cases. Furthermore, continuous innovations and enhancements regarding filter designs are also facilitated by the US FDA guidelines that have helped cling such advanced healthcare infrastructure. North America is a region with large IVC filter manufacturing companies and considerable investments in healthcare technology. In the United States and Canada, health care spending is extravagantly high, and adoption of advanced medical devices is early. North America thus remains a leader in the global IVC filter market. Active Key Players in the Inferior Vena Cava (IVC) Filter Market: C. R. Bard, Inc. (USA) Cook Medical (USA) Boston Scientific Corporation (USA) Cardinal Health (USA) B. Braun Melsungen AG (Germany) ALN (France) Argon Medical Devices (USA) Cordis Corporation (USA) Medtronic Plc. (Ireland) Stryker Corporation (USA) Abbott Laboratories (USA) Terumo Corporation (Japan) Other Active Players Key Industry Developments in the Inferior Vena Cava (IVC) Filter Market: February 2023: Cook Medical received FDA approval for its Celect Vena Cava Filter, a new generation of retrievable IVC filter. The Celect Vena Cava Filter is designed to be more flexible and easier to insert than previous generations of filters, and it also has a retrieval rate of over 90%. January 2023: Bard Access Systems announced that it has received FDA approval for its Eclipse IVC Filter, a new generation of permanent IVC filter. The Eclipse IVC Filter is designed to be more durable and less likely to migrate than previous generations of filters. December 2022: Boston Scientific acquired Veniti, a company that develops IVC filters that are designed to be more retrievable than traditional filters. The acquisition is expected to strengthen Boston Scientific's position in the IVC filter market. CONTACT US:-INTROSPECTIVE MARKET RESAERCHCALL:- +91 91753-37569.EMAIL:- info@introspectivemarketresearch.com

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.